Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

The development of 13-valent pneumococcal conjugate vaccine and its possible use in adults.

Frenck RW Jr, Yeh S.

Expert Opin Biol Ther. 2012 Jan;12(1):63-77. doi: 10.1517/14712598.2012.636348. Epub 2011 Nov 10. Review.

PMID:
22074323
2.

The future of pneumococcal disease prevention.

Rodgers GL, Klugman KP.

Vaccine. 2011 Sep 14;29 Suppl 3:C43-8. doi: 10.1016/j.vaccine.2011.07.047.

PMID:
21896352
4.

Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).

Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices.

MMWR Morb Mortal Wkly Rep. 2010 Sep 3;59(34):1102-6.

5.

Use of the 13-valent pneumococcal conjugate vaccine in children and adolescents aged 6 - 17 years.

Mitchell R, Trück J, Pollard AJ.

Expert Opin Biol Ther. 2013 Oct;13(10):1451-65. doi: 10.1517/14712598.2013.824419. Epub 2013 Jul 29. Review.

PMID:
23889554
6.

The worldwide impact of the seven-valent pneumococcal conjugate vaccine.

Fitzwater SP, Chandran A, Santosham M, Johnson HL.

Pediatr Infect Dis J. 2012 May;31(5):501-8. doi: 10.1097/INF.0b013e31824de9f6.

PMID:
22327872
7.

Pneumococcal conjugate vaccines. A review.

Galiza EP, Heath PT.

Minerva Med. 2007 Apr;98(2):131-43. Review.

PMID:
17519855
8.

The potential role for protein-conjugate pneumococcal vaccine in adults: what is the supporting evidence?

Musher DM, Sampath R, Rodriguez-Barradas MC.

Clin Infect Dis. 2011 Mar 1;52(5):633-40. doi: 10.1093/cid/ciq207.

PMID:
21292668
9.

Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).

American Academy of Pediatrics Committee on Infectious Diseases.

Pediatrics. 2010 Jul;126(1):186-90. doi: 10.1542/peds.2010-1280. Epub 2010 May 24.

PMID:
20498180
10.

Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?

Fenoll A, Aguilar L, Granizo JJ, Giménez MJ, Aragoneses-Fenoll L, Mendez C, Tarragó D.

J Antimicrob Chemother. 2008 Dec;62(6):1430-3. doi: 10.1093/jac/dkn413. Epub 2008 Sep 26.

PMID:
18819966
11.

Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.

Zangeneh TT, Baracco G, Al-Tawfiq JA.

Expert Rev Vaccines. 2011 Mar;10(3):345-53. doi: 10.1586/erv.11.1. Review.

PMID:
21434802
12.
13.

The new pneumococcal vaccine.

Obaro SK.

Clin Microbiol Infect. 2002 Oct;8(10):623-33. Review.

14.

Pneumococcal conjugated vaccine: PHiD-CV.

Dinleyici EC, Yargic ZA.

Expert Rev Anti Infect Ther. 2009 Nov;7(9):1063-74. doi: 10.1586/eri.09.84.

PMID:
19883326
15.

Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.

Tyo KR, Rosen MM, Zeng W, Yap M, Pwee KH, Ang LW, Shepard DS.

Vaccine. 2011 Sep 2;29(38):6686-94. doi: 10.1016/j.vaccine.2011.06.091. Epub 2011 Jul 13.

PMID:
21745516
16.

Pneumococcal conjugate vaccine for young children.

Selman S, Hayes D, Perin LA, Hayes WS.

Manag Care. 2000 Sep;9(9):49-52, 54, 56-7 passim. Review.

17.

Pneumococcal vaccination in adults: does it really work?

Pitsiou GG, Kioumis IP.

Respir Med. 2011 Dec;105(12):1776-83. doi: 10.1016/j.rmed.2011.07.008. Epub 2011 Aug 4. Review.

18.

Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.

Cheung YB, Zaman SM, Nsekpong ED, Van Beneden CA, Adegbola RA, Greenwood B, Cutts FT.

Pediatr Infect Dis J. 2009 Nov;28(11):990-5. doi: 10.1097/INF.0b013e3181a78185.

PMID:
19536041
19.

Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine.

Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Mitchel E, Schaffner W, Craig AS, Edwards KM, Griffin MR.

Clin Infect Dis. 2004 Sep 1;39(5):641-8. Epub 2004 Aug 16.

PMID:
15356776
20.

Supplemental Content

Support Center